Sage Private Wealth Group’s Cardinal Health CAH Stock Holding History

Sage Private Wealth Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-201	Closed	-$13K	–	64
2022 Q3	$13K	Buy	+201	New	+$12.7K	0.02%	130

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Sage Private Wealth Group's CAH Position: Q4 2022 in Review

Sage Private Wealth Group sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 201 shares — an estimated $13K sold.

Sage Private Wealth Group first reported a position in CAH in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 930 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

Sage Private Wealth Group reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
Sage Private Wealth Group sold 201 Cardinal Health shares in Q4 2022, an estimated $13K.
Sage Private Wealth Group first reported a position in Cardinal Health in Q3 2022 and held it in 1 quarter.
Sage Private Wealth Group's Cardinal Health position peaked at $13K in Q3 2022.
930 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Sage Private Wealth Group's 13F filing for Q4 2022, filed 29 Jan 2025.